Classification System for Oral Submucous Fibrosis

More, Chandramani B.; Gupta, Swati; Joshi, Jigar; Verma, S.; Kailasam, S

doi:10.5005/jp-journals-10011-1254

Cited by 46 publications

(15 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Approval from the institutional ethical committee was obtained for the study. Patients with OSMF (Stage 2 according to Pindborg) were enrolled in the study. Pregnant women, lactating mothers, patients with known history of hypersensitivity to aloe vera, and those who had received prior treatment for OSMF were excluded.…”

Section: Methodsmentioning

confidence: 99%

Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis – a clinical study

Anuradha

Patil

Asha

2016

J Oral Pathology Medicine

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis – a clinical study

Anuradha

Patil

Asha

2016

J Oral Pathology Medicine

View full text Add to dashboard Cite

show abstract

“…These staging proposals were mostly based on distribution and location of fibrous bands in the oral cavity (Haider et al, 2000, Bhagvan More et al, 2012). Another staging proposal was based on mouth opening measurements in OSF patients (Haider et al, 2000, Bhagvan More et al, 2012, Passi et al, 2017), however many of the OSF staging systems do not consider the normal mouth opening limit of a person when assessing reduction in mouth opening. In this study we have considered the normal maximum mouth opening capacity of an individual in assessing the reduction in mouth opening.…”

Section: Discussionmentioning

confidence: 99%

“…The various clinical and functional stagings were done earlier without considering the normal maximum mouth-opening limit of an individual (Haider et al, 2000, Bhagvan More et al, 2012, Patil and Maheshwari, 2014, Jani and Dudhia, 2016, Passi et al, 2017). The TFI is an established method to estimate a normal maximum mouth-opening limit in an individual and was used by different authors (Chima and Obiechina, 1995, Zawawi et al, 2003, Agrawal et al, 2015).…”

Section: Discussionmentioning

confidence: 99%

Establishing a new staging system for oral submucous fibrosis and correlation of the proposed staging system to traditional histopathological grading: A clinico-histopathological study

Hameed

Chatra

Shenai

2019

The Saudi Dental Journal

View full text Add to dashboard Cite

Background & objectivesOral submucous fibrosis (OSF) is a potentially malignant disorder of the oral cavity leading to reduction in mouth opening. Mouth opening assessment is used as one of the methods to assess the severity of the disease. In this study the normal maximum mouth-opening capacity of an individual is considered in assessing the reduction in mouth opening. This study was done to establish a new clinical staging pattern in OSF and to evaluate the relationship between the proposed staging system and traditional histopathological grading system of OSF.Materials and methodsThe study included 50 clinically diagnosed OSF patients. Normal mouth opening was established by measuring three-finger index (TFI). Existing maximum mouth opening was established by measuring the interincisal distance. Presence of palpable vertical bands was recorded. Histopathological grading was done according to Pindborg and Sirsat. Percentage of reduction in mouth opening (PRMO) was calculated and the mean of PRMO in different clinical and histopathological stages was analysed by fisherman’s extract test. A new staging pattern for OSF was proposed from the data.ResultsPRMO was assessed at different clinical stages. A range between 16% and 47% was obtained, and statistically the p value of <0.001 was very highly significant. Similarly, a range between 17% and 45.6% was obtained when PRMO was assessed at different histopathological grading; again the statistical value was very highly significant with a p value of <0.001.ConclusionWith the data obtained from our study, the following clinical staging pattern can be adapted: stage I indicates that the PRMO is <30%, Stage II between 30–45%, and stage III >45%. Hence it may be appropriate to asses the disease severity and stage by assessing the degree of disability (i.e., mouth opening reduction considering the individual normal mouth opening ability). The determination of PRMO may be a useful tool in this direction.

show abstract

“…Pindborg classification 10,11 was used as diagnostic criteria for oral mucosal changes with focus on submucous fibrosis. (Table 1)…”

Section: Oral Examinationmentioning

confidence: 99%

Tobacco use and oral mucosal changes in Baiga tribals of Madhya Pradesh

Agarwal¹,

Bhattacharya²

2020

JCHM

View full text Add to dashboard Cite

Background: Tobacco use leads to oral mucosal changes and submucous fibrosis. Use of tobacco products is common amongst primitive tribes for various purposes leading to high prevalence of oral lesions. Objectives: To estimate the prevalence of oral mucosal changes amongst tobacco users, to identify the factors contributing to increased tobacco use and suggest strategies for prevention. Materials and Methods: A cross-sectional study was conducted amongst primitive Baiga tribe at Mandla block in Mandla district of Madhya Pradesh. Multistage random sampling method used to select the study villages with predominantly Baiga families. Prevalence of mucosal changes estimated by pilot study 41% was used to calculate sample size of 540. Data was elicited by interview and clinical examination after consent. Diagnosis was according to various stages of Pindborg classification for oral mucosal fibrosis. Data is analysed in MExcel and prevalence values presented as percentages. Chi sq test and odds ratio calculated to express association and risk estimate. Results: All the 540 study subjects were of low socio economic status. A total of 256 (47.4%) developed oral mucosal changes as per the Pindborg classification for oral submucosal fibrosis. Amongst the 296 tobacco users 77% developed oral mucosal changes compared to 11.5% for non-users. (Odds ratio= 25.8. CI 16.03 to 41.71). Majority 59% had stage 1 changes in oral mucosa presenting as mucosal ulcers, erythema, melanotic pigmentation and petechiae ranging between 27 t0 18%, while 35% presented in stage 2 with fibrous bands in 19.3%. Leukoplakia observed in 5.8% The age group with maximum cases was 21-40 years but 53.6% amongst 10 to 19 years, had oral lesions. Extensive use of tobacco products (Nas&Gudhaku) as dental cleanser and other purposes caused addictions from young age. Lack of awareness, social norm and easy availability aggravated the condition. Conclusion: The current study highlights the problem of oral mucosal changes and OSMF amongst those in the primitive Baiga tribals due to social norm, cheap colourful packets easily available in the local market, and finally addiction. The high prevalence and continued use noted in our study reflect the absence of any preventive and promotive measures by the health personnel for the tribe. The Tobacco Control Act need to be reinforced there and targeted intervention for the welfare of the tribe be introduced to manage the menance.

show abstract

Classification System for Oral Submucous Fibrosis

Cited by 46 publications

References 14 publications

Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis – a clinical study

Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis – a clinical study

Establishing a new staging system for oral submucous fibrosis and correlation of the proposed staging system to traditional histopathological grading: A clinico-histopathological study

Tobacco use and oral mucosal changes in Baiga tribals of Madhya Pradesh

Contact Info

Product

Resources

About